Research Article

The Influence of BMX Gene Polymorphisms on Clinical Symptoms after Mild Traumatic Brain Injury

Table 3

(a) Difference in BAI score among mTBI patients stratified by different BMX genotypes (First week). (b) Difference in BAI score among mTBI patients stratified by different BMX genotypes (sixth week).
(a)

SNPGenotypeNumber Grade 1
(0–9)
Grade 2
(10–18)
Grade 3
(19–29)
Grade 4
(30–63)
aOR (95% CI)
P value
bFisher’s exact test
P value

rs35697037AA + AG107 67 (62.6)22 (20.6)14 (13.1) 4 (3.7)1.40
GG79 50 (63.3)19 (24.0)7 (8.9) 3 (3.8)(0.61–3.21)
0.5352

rs16979956TT + CT3 1 (33.3)0 (0.0) 1 (33.3) 1 (33.3)12.08
CC183116 (63.4)41 (22.4)20 (10.9) 6 (3.3)(1.06–138.01)
0.0597

rs1877752TT + CT9 4 (44.4) 2 (22.2) 3 (33.3) 0 (0.0)3.04
CC177 113 (63.8)39 (22.0)18 (10.2)7(4.0)(0.71–12.95)
0.11590.1372

rs16997078GG + AG7 4 (57.1) 1 (14.3)0 (0.0) 2 (28.6)2.35
AA179 113 (63.1)40 (22.4)21 (11.7)5 (2.8)(0.43–12.78)
0.30800.2841

is labeled in bold. Grade 1 + Grade 2 versus Grade 3 + Grade 4. b20% of cells has expected count less than 5, Fisher’s exact test would be performed.
(b)

SNPGenotypeNumber Grade 1
(0–9)
Grade 2
(10–18)
Grade 3
(19–29)
Grade 4
(30–63)
aOR (95% CI)
P value
bFisher’s exact test
P value

rs35697037AA + AG6446 (71.9)10 (15.6) 7 (10.9)1 (1.6)1.29
GG4032 (80.0) 4 (10.0) 3 (7.5)1 (2.5)(0.36–4.58)
0.69780.7635

rs16979956TT + CT 1 1 (100.0)0 (0.0) 0 (0.0) 0 (0.0)0
CC10377 (74.8)14 (13.6)10 (9.7)2 (1.9)
0.71671.0000

rs1877752TT + CT4 3 (75.0) 1 (25.0) 0 (0.0)0 (0.0)0
CC10075 (75.0)13 (13.0) 10 (10.0)2 (2.0)
0.46141.0000

rs16997078GG + AG4 2 (50.0) 1 (25.0) 1 (25.0)0 (0.0)2.70
AA10076 (76.0)13 (13.0) 9 (9.0)2 (2.0)(0.26–28.23)
0.39010.3923

Grade 1 + Grade 2 versus Grade 3 + Grade 4. b20% of cells has expected count less than 5, Fisher’s exact test would be performed.